A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.
about
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsApplications of regenerative medicine in organ transplantationCurrent status of hematopoietic stem cell transplant in chronic myeloid leukemiaRegulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agentInterpreting outcome data in hematopoietic cell transplantation for leukemia: tackling common biases.Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration.Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.Hematopoietic stem cell transplantation: a primer for the primary care physicianAllogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials.Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioningMulticenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?The EBMT Risk Score in the Presence of Graft Versus Host Disease in Allogeneic Stem Cell Transplantation in Adult Acute Myelogenous Leukemia: A Multistate Model for Competing RisksOptimal stem cell source for allogeneic stem cell transplantation for hematological malignancies.Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignanciesHarvesting, processing and inventory management of peripheral blood stem cellsHaematopoietic stem cell transplantation: indications, clinical developments and future directions.CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.Role of stem cells in cancer therapy and cancer stem cells: a review.Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.Current status of allogeneic hematopoietic cell transplantation for MDS.Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell tNutrition issues in hematopoietic stem cell transplantation: state of the art.The hematopoietic system in the context of regenerative medicine.Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations.Allogeneic transplantation: peripheral blood vs. bone marrow.Management of acute graft-versus-host disease.Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: the past decade.HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.Peripheral-blood stem cells versus bone marrow from unrelated donorsIs mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors.Stem cell transplant for chronic myeloid leukemia in the imatinib eraCellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics.
P2860
Q24195048-062CBF2E-473C-466E-9696-969CA756179CQ26801226-D9BCDF62-2556-4FFE-88C8-2AC527AD9E6EQ27010475-540A881E-D589-4607-9F83-57F3ECCABA10Q27692619-13FC7255-1543-48BC-8E82-AE76BFAD3F7EQ28286940-C54110CE-498F-416D-892E-A60F4886E6E0Q30884173-85D1DD9B-BEA0-46C2-BF13-CADB7E387921Q30997153-F1C356E7-415B-40DC-AE8B-B8DF543C2B43Q31058878-DF70524F-18E1-4C58-A4BC-24843D6320D2Q33365781-0C6CECB8-47EB-442A-8679-BE57E60B26EDQ33555232-B87CAAE5-7C1C-44E8-8327-2E917F7D9C7BQ33971524-E884D423-CA11-4FF3-A37C-6D9088A82F35Q34402494-98993B87-DD3C-4D2C-B32A-A93A58AAE691Q34544439-D75769B3-FE48-4446-A841-5BDE7DF1C890Q34743469-D0641D74-9D01-484A-B56A-7747A242B42FQ35009266-5C24CAA5-B778-4221-B227-6B38DD813330Q35083562-A616E664-C05C-4BAA-BC90-D1B6B8E6352DQ35133894-EEB42EBF-15DD-48A8-AB49-8C4E6AE6F2E4Q35199782-7ED9BA62-C228-4E8B-8358-AB5670631C1CQ35609690-49B5B4CD-E44E-4CE8-86A0-A6620B417C8FQ35733259-D3C2D6E0-E198-4725-8C4D-229374307DE8Q35800814-45D1D64F-FCA0-4CDE-BB71-7F7D9E182B4CQ35846826-8BBF266B-FB1A-4791-B29B-F9287D70D7E6Q35848787-768D39CF-7D6A-46D2-925C-2C2F6296C7A2Q36063049-0006CB86-D802-462E-A2B5-930968621CBDQ36212392-F1A51AEC-A348-44C8-9EA5-0496CDBECE7CQ36278418-DC9003D0-7A35-440D-A24E-E4C25D683717Q36627127-AA86106E-3784-4E32-A260-D60C8E609933Q36712054-44F0320F-66FA-4BFE-A498-14D17F97CA7CQ36761427-8F463949-18E1-4CE7-B2FD-8B9ADDA02B82Q36773002-75A66217-C1A4-4B92-8E31-146B7B964EACQ36811828-3D14FDBD-72D7-4A87-AB41-F5323874C002Q36865630-67D435E3-6106-4C43-8515-EB7322CE4FCBQ37235001-5FA11B6A-93E9-417D-B791-46D00597B77FQ37263146-A9FB3043-8BE9-4722-B4A2-581EE7D861E4Q37276359-CCB86AAF-E1DA-443F-8072-53ADAE2E6C47Q37334978-7A5EC7CD-DD12-4D41-A69D-F8AE90346EC3Q37480306-AE11D46E-4581-4B0A-A78E-B42E6D7DA93DQ37618917-9F6ED4A7-A691-4A27-8880-354646871A87Q37793491-71468981-FD46-426F-B704-E1B1D7A7727FQ37954790-EF0F6EE2-CC23-4504-8A91-B869CE8651FF
P2860
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A randomized multicenter compa ...... ants for myeloid malignancies.
@ast
A randomized multicenter compa ...... ants for myeloid malignancies.
@en
A randomized multicenter compa ...... ants for myeloid malignancies.
@nl
type
label
A randomized multicenter compa ...... ants for myeloid malignancies.
@ast
A randomized multicenter compa ...... ants for myeloid malignancies.
@en
A randomized multicenter compa ...... ants for myeloid malignancies.
@nl
prefLabel
A randomized multicenter compa ...... ants for myeloid malignancies.
@ast
A randomized multicenter compa ...... ants for myeloid malignancies.
@en
A randomized multicenter compa ...... ants for myeloid malignancies.
@nl
P2093
P921
P1433
P1476
A randomized multicenter compa ...... lants for myeloid malignancies
@en
P2093
Canadian Bone Marrow Transplant Group
Christopher Bredeson
Hans A Messner
Irwin R Walker
Jeffrey H Lipton
Kang Howson-Jan
Lothar Hubesch
Michael J Barnett
Peter Browett
Stephen Couban
P304
P356
10.1182/BLOOD-2002-01-0048
P407
P577
2002-09-01T00:00:00Z